Liberato 3 , Sonya Eremenco 1 1 Critical Path Institute, Tucson, Arizona, USA, 2 Evidera, Wilmington, North Carolina, USA, 3 Evidera, London, UK Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :1002 Aims Based on emerging technologies enabling data collection via mobile sensor devices (e.g., activity monitors), there is increasing interest in leveraging them to collect clinical trial endpoint data in persons with chronic heart failure (CHF)
Por que a substncia no autorizada Segundo Heimbecher, o principal problema que os testes em seres humanos no foram concludos , o que significa que a substncia ainda no possui aprovao de rgos regulatrios como a Anvisa ou a Food and Drug Administration (FDA) para uso clnico fora de protocolos de pesquisa
ab133999) was purchased from Abcam Inc
ALMACENAMIENTO Conservar en un lugar oscuro y seco a temperatura ambiente